Anti-HER2 therapy may be omitted in patients with HER2+ ILC (of 11) Pediatric News , 24 Feb 2023 Key clinical point: Survival outcomes in human epidermal growth factor receptor 2-positive (HER2+) invasive lobular carcinoma (IL…